aTyr Pharma (FRA:471A) Shares Buyback Ratio % : -26.53 (As of May. 13, 2025)

View and export this data going back to 2016. Start your Free Trial

What is aTyr Pharma Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. aTyr Pharma's current shares buyback ratio was -26.53%.

aTyr Pharma Shares Buyback Ratio % Historical Data

The historical data trend for aTyr Pharma's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

aTyr Pharma Shares Buyback Ratio % Chart

aTyr Pharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Shares Buyback Ratio %

Get a 7-Day Free Trial

-183.12

-152.23

-6.13

-114.54

-32.79

aTyr Pharma Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Shares Buyback Ratio %	Get a 7-Day Free Trial															-8.01	-10.89	-0.02	-10.85	-2.91

aTyr Pharma Shares Buyback Ratio % Calculation

aTyr Pharma's Shares Buyback Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2023 )	-	Shares Outstanding (EOP) (A: Dec. 2024 ))	/	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	(63.286	-	84.039)	/	63.286
	=	-32.79%

aTyr Pharma's Shares Buyback Ratio for the quarter that ended in Mar. 2025 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2024 )	-	Shares Outstanding (EOP) (A: Mar. 2025 ))	/	Shares Outstanding (EOP) (A: Dec. 2024 )
	=	(84.039	-	86.485)	/	84.039
	=	-2.91%

aTyr Pharma Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of aTyr Pharma's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

aTyr Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » aTyr Pharma Inc (FRA:471A) » Definitions » Shares Buyback Ratio %

Comparable Companies

Traded in Other Exchanges

ATYR:USA

Address

10240 Sorrento Valley Road, Suite 300, San Diego, CA, USA, 92121

Website

https://www.atyrpharma.com

aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.

aTyr Pharma Headlines

No Headlines